Neonatal protection and preterm birth reduction following maternal group B streptococcus vaccination in a mouse model

References

• Berardi A, Cattelani C, Creti R, et al. Group B streptococcal infections in the newborn infant and the potential value of maternal vaccination. Expert Rev anti Infect Ther 2015;13:1387–99.
   PubMed Web of Science ®Google Scholar
• Heath PT, Schuchat A. Perinatal group B streptococcal disease. Best Pract Res Clin Obstet Gynaecol 2007;21:411–24.
   PubMed Web of Science ®Google Scholar
• Goldenberg RL, Hauth JC, Andrews WW. Intrauterine infection and preterm delivery. N Engl J Med 2000;342:1500–7.
   PubMed Web of Science ®Google Scholar
• Romero R, Dey SK, Fisher SJ. Preterm labor: one syndrome, many causes. Science 2014;345:760–5.
   PubMed Web of Science ®Google Scholar
• Boyer KM, Gadzala CA, Burd LI, et al. Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. I. Epidemiologic rationale. J Infect Dis 1983;148:795–801.
   PubMed Web of Science ®Google Scholar
• Kubota T. Relationship between maternal group B streptococcal colonization and pregnancy outcome. Obstet Gynecol 1998;92:926–30.
   PubMed Web of Science ®Google Scholar
• McDonald H, Vigneswaran R, O'Loughlin JA. Group B streptococcal colonization and preterm labour. Aust N Z J Obstet Gynaecol 1989;29:291–3.
   PubMed Web of Science ®Google Scholar
• Regan JA, Klebanoff MA, Nugent RP, et al. Colonization with group B streptococci in pregnancy and adverse outcome. VIP Study Group. Am J Obstet Gynecol 1996;174:1354–60.
   PubMed Web of Science ®Google Scholar
• Vornhagen J, Quach P, Boldenow E, et al. Bacterial hyaluronidase promotes ascending GBS infection and preterm birth. MBio 2016;7:e00781–16. doi: 10.1128/mBio.00781-16.
   PubMed Web of Science ®Google Scholar
• Phares CR, Lynfield R, Farley MM, Active Bacterial Core surveillance/Emerging Infections Program N, et al. Epidemiology of invasive group B streptococcal disease in the United States, 1999–2005. JAMA 2008;299:2056–65.
   PubMed Web of Science ®Google Scholar
• Jordan HT, Farley MM, Craig A, Active Bacterial Core Surveillance/Emerging Infections Program Network CDC, et al. Revisiting the need for vaccine prevention of late-onset neonatal group B streptococcal disease: a multistate, population-based analysis. Pediatr Infect Dis J 2008;27:1057–64.
   PubMed Web of Science ®Google Scholar
• Stoll BJ, Hansen NI, Sanchez PJ, Eunice Kennedy Shriver National Institute of Child H, Human Development Neonatal Research N, et al. Early onset neonatal sepsis: the burden of group B Streptococcal and E. coli disease continues. Pediatrics 2011;127:817–26.
   PubMed Web of Science ®Google Scholar
• Schrag SJ, Verani JR. Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: experience in the United States and implications for a potential group B streptococcal vaccine. Vaccine 2013;31:D20–6.
   PubMed Web of Science ®Google Scholar
• Pettersson K. Perinatal infection with Group B streptococci. Semin Fetal Neonatal Med 2007;12:193–7.
   PubMed Web of Science ®Google Scholar
• Baker CJ, Kasper DL. Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection. N Engl J Med 1976;294:753–6.
   PubMed Web of Science ®Google Scholar
• Lin FY, Philips JB 3rd, Azimi PH, et al. Level of maternal antibody required to protect neonates against early-onset disease caused by group B Streptococcus type Ia: a multicenter, seroepidemiology study. J Infect Dis 2001;184:1022–8.
   PubMed Web of Science ®Google Scholar
• Adkins B, Leclerc C, Marshall-Clarke S. Neonatal adaptive immunity comes of age. Nat Rev Immunol 2004;4:553–64.
   PubMed Web of Science ®Google Scholar
• Gallorini S, Berti F, Mancuso G, et al. Toll-like receptor 2 dependent immunogenicity of glycoconjugate vaccines containing chemically derived zwitterionic polysaccharides. Proc Natl Acad Sci USA 2009;106:17481–6.
   PubMed Web of Science ®Google Scholar
• Margarit I, Rinaudo CD, Galeotti CL, et al. Preventing bacterial infections with pilus-based vaccines: the group B streptococcus paradigm. J Infect Dis 2009;199:108–15.
   PubMed Web of Science ®Google Scholar
• Ancona RJ, Ferrieri P. Experimental vaginal colonization and mother-infant transmission of group B streptococci in rats. Infect Immun 1979;26:599–603.
   PubMed Web of Science ®Google Scholar
• Randis TM, Gelber SE, Hooven TA, et al. Group B Streptococcus beta-hemolysin/cytolysin breaches maternal-fetal barriers to cause preterm birth and intrauterine fetal demise in vivo. J Infect Dis 2014;210:265–73.
   PubMed Web of Science ®Google Scholar
• Zucchelli S, Capone S, Fattori E, et al. Enhancing B- and T-cell immune response to a hepatitis C virus E2 DNA vaccine by intramuscular electrical gene transfer. J Virol 2000;74:11598–607.
   PubMed Web of Science ®Google Scholar
• Treuting PM, Dintzis SM, Frevert CW, et al. Comparative anatomy and histology: a mouse and human atlas. 1st ed. Amsterdam, Boston: Elsevier/Academic Press; 2012.
   Google Scholar
• Hirsch E, Wang H. The molecular pathophysiology of bacterially induced preterm labor: insights from the murine model. J Soc Gynecol Investig 2005;12:145–55.
   PubMedGoogle Scholar
• Jerse AE, Wu H, Packiam M, et al. Estradiol-treated female mice as surrogate hosts for Neisseria gonorrhoeae genital tract infections. Front Microbiol 2011;2:107. doi: 10.3389/fmicb.2011.00107.
   PubMed Web of Science ®Google Scholar
• Santi I, Maione D, Galeotti CL, et al. BibA induces opsonizing antibodies conferring in vivo protection against group B Streptococcus. J Infect Dis 2009;200:564–70.
   PubMed Web of Science ®Google Scholar
• Lauer P, Rinaudo CD, Soriani M, et al. Genome analysis reveals pili in Group B Streptococcus. Science 2005;309:105. doi: 10.1126/science.1111563.7.
   PubMed Web of Science ®Google Scholar
• Pentsuk N, van der Laan JW. An interspecies comparison of placental antibody transfer: new insights into developmental toxicity testing of monoclonal antibodies. Birth Defects Res B Dev Reprod Toxicol 2009;86:328–44.
   PubMed Web of Science ®Google Scholar
• Donders GG, Halperin SA, Devlieger R, et al. Maternal immunization with an investigational trivalent Group B streptococcal vaccine: a randomized controlled trial. Obstet Gynecol 2016;127:213–21.
   PubMed Web of Science ®Google Scholar
• Heyderman RS, Madhi SA, French N, et al. Group B streptococcus vaccination in pregnant women with or without HIV in Africa: a non-randomised phase 2, open-label, multicentre trial. Lancet Infect Dis 2016;16:546–55.
   PubMed Web of Science ®Google Scholar
• Madhi SA, Cutland CL, Jose L, et al. Safety and immunogenicity of an investigational maternal trivalent group B streptococcus vaccine in healthy womenand their infants: a randomised phase 1b/2 trial. Lancet Infect Dis 2016;16:923–34.
   PubMed Web of Science ®Google Scholar
• Kim SY, Russell LB, Park J, et al. Cost-effectiveness of a potential group B streptococcal vaccine program for pregnant women in South Africa. Vaccine 2014;32:1954–63.
   PubMed Web of Science ®Google Scholar
• Berardi A, Ferrari F. Group B streptococcal maternal vaccination, the goal is near. Lancet Infect Dis 2016;16:871–2.
   PubMed Web of Science ®Google Scholar
• Kobayashi M, Vekemans J, Baker CJ, et al. Group B Streptococcus vaccine development: present status and future considerations, with emphasis on perspectives for low and middle income countries. F1000Res 2016;5:2355. eCollection 2016.
   PubMedGoogle Scholar